
    
      A prospective randomized controlled trial of patients with a presumptive diagnosis of acute
      pyelonephritis caused by Extended Spectrum Beta Lactamase-producing pathogen was performed.
      Carbapenems was initially given to all patients. After day 3, patients were randomized to
      receive either oral sitafloxacin (100 mg twice daily) or intravenous ertapenem. The regular
      course of treatment was completed within 10 days.
    
  